NCT01823822已完成2 期
Influence of Protein Supplements on Serum Insulin-like Growth Factor-I Levels in Women With Anorexia Nervosa
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 62
- 试验地点
- 1
- 主要终点
- Serum insulin like growth factor-1 (IGF-I) level
研究概览
简要总结
This multicentre, randomised, double-blind, 2-parallel group, controlled trial aims to investigate whether oral milk protein supplements led to increase in serum Insulin-like Growth Factor-I levels (IGF-I) as compared with a control group fed with an iso-caloric supplement, in women with anorexia nervosa. Subjects receive either 150g/day of tested product or control product for 4-week, followed by a 4-week follow-up.
详细描述
Study centres: 4 active centres in France and 2 active centres in Switzerland
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 40 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Women aged between 18 to 40 years (bounds included).
- •Women with a serum IGF-I level below the 25th percentile of the reference value according to the age (bounds included).
- •Women who had given written inform consent.
- •Women with DSM-IV-confirmed anorexia nervosa lasting for at least 6 months. Women with concomitant binge eating and purging type are also included.
- •Women admitted in-hospital for weight and nutritional rehabilitation. It is anticipated that the patient will stay in-hospital during the full duration of the 4-week supplementation phase, and at least 5 weeks within the study.
- •Women being already regular consumers of dairy products.
- •For women with childbearing potential, use of a contraceptive method.
- •Discontinuation of any mineral and vitamin supplements containing calcium and vitamin D, 1 week before starting the product consumption and during the study.
排除标准
- •Women with primary amenorrhea;
- •Women with lactose intolerance;
- •Women with any other metabolic disease that could affect bone metabolism: osteogenesis imperfecta, Paget's disease of bone, hyperthyroidism, primary hyperparathyroidism;
- •Women with current or past neoplasm;
- •Women with any other severe comorbidity;
- •Pregnant or breast feeding women;
- •Women with epilepsy;
- •Women with any current or past use of the following treatments: bisphosphonates, calcitonin, steroids;
- •Patients enrolled in another clinical study within the last 4 weeks;
- •Patients having already received oral nutritional supplements or who need to receive other oral or intravenous (IV) supplements during the follow-up;
- •Patients having received oral or IV nutritional supplements within two weeks before the inclusion;
- •Patients having willed to participate in another clinical study during the present study phase and 4 weeks after the end of their participation in the present study.
结局指标
主要结局
Serum insulin like growth factor-1 (IGF-I) level
时间窗: 4-week
The main study product effect criterion is the IGF-I level over the 4-week consumption period.
次要结局
未报告次要终点
研究者
Rene Rizzoli
René Rizzoli, MD (Principal Investigator)
University Hospital, Geneva
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Dietary Protein and Insulin Sensitivity StudyMetabolic SyndromeType 2 DiabetesCardiovascular DiseaseInsulin ResistanceDyslipidemiaNCT00508937UCSF Benioff Children's Hospital Oakland660
已完成
不适用
Protein Intake & Insulin ActionObesityNCT02004002Washington University School of Medicine15
招募中
1 期
The Effects of Dietary Supplementation on Serum Protein GlycosylationHealthyNCT05040204University of California, Davis44
Unknown
不适用
Dietary Protein and Resistance Exercise in ElderlyAgingNCT04023513University of Vienna137
已完成
不适用
Glycemic Response in Persons with Type 2 DiabetesDiabetes Mellitus, Type 2NCT04413357Société des Produits Nestlé (SPN)14